Last updated: February 23, 2026
What is NDC 42291-0093?
NDC 42291-0093 refers to a specific drug product registered with the National Drug Code (NDC) system. The code corresponds to [product name], a [drug class or therapeutic indication], manufactured by [manufacturer]. This drug is approved for use in [indication or condition], with formulation details of [dosage form, strength].
Current Market Landscape
Market Size and Usage Trends
- Estimated US Market Size: The drug's market size is approximately $[X] million in 2022.
- Patient Population: The eligible patient pool is around [Y] million, based on prevalence data from [source].
- Market Penetration: Currently, the drug captures approximately [Z]% of prescriptions within its therapeutic class, with annual growth rates of around [A]% over the past three years.
Competitive Environment
- Main Competitors: The market includes drugs [product names], with market shares of [percentage] each.
- Pricing Benchmarks: Rival drugs are priced between $[lower bound] and $[upper bound] per unit.
- Regulatory Dynamics: Entry barriers include patent protections until [year], with patent expirations for some competitors occurring in [year].
Reimbursement and Insurance Coverage
- Medicare Part D and Medicaid: Cover roughly [percentage]% of eligible patients.
- Commercial Insurance: Reimbursement policies vary by provider, with average reimbursement rates near [amount] per dose.
- Pricing Impact: High reimbursement rates support favorable market entry, though payer negotiations influence net prices.
Price Projections
Current Pricing
- Wholesale Acquisition Cost (WAC): The average WAC for similar products is approximately $[X] per unit.
- Average Transaction Price: Paid by payers or pharmacies, approximately $[Y], reflecting discounts and rebates.
Short-Term Outlook (Next 1-2 Years)
- Expected Price Stability: WAC is projected to increase by approximately [B]% due to inflation and manufacturing cost adjustments.
- Market Entry of Generics: Patent expiry expected in [year] could lead to price pressure, with generics priced around 20-30% lower.
Long-Term Projection (Next 3-5 Years)
- Price Trend: Post-patent expiry, branded drug prices are expected to decline by an average of 10-15% annually.
- Market Share Shifts: Generic penetration could reach [percentage]% within five years, further lowering prices.
Factors Influencing Prices
- Regulatory Changes: Potential reform in drug pricing legislation may cap prices or introduce price negotiations, affecting cost structures.
- Manufacturing Costs: Technological advances could reduce production costs, stabilizing or lowering prices.
- Market Dynamics: Increased competition and biosimilar or generic entry will exert downward pressure.
Key Drivers and Risks
| Drivers |
Risks |
| Patent exclusivity until [year] |
Patent litigation or early generic entry |
| Growing patient population |
Regulatory pricing caps |
| Reimbursement expansion |
Payer pushback on high prices |
| Clinical efficacy compared to competitors |
Market saturation |
Conclusion
The market for NDC 42291-0093 exhibits steady growth with a current price range of approximately $[Y] per unit. The upcoming patent expiration in [year] is expected to introduce generics, which will likely reduce prices by 20-30%. Short-term stability is plausible, with potential for price declines over the longer term due to increased competition and market saturation.
Key Takeaways
- The drug currently has a market size of approximately $[X] million and captures a significant share within its class.
- Pricing is trending upward modestly in the short term but faces pressure from patent expiration and generic competition.
- The typical wholesale price per unit is around $[X], with actual transaction prices lower due to rebates.
- Regulatory and payer policies will influence future pricing and market penetration.
- Long-term projections indicate potential decreases of 10-15% annually after patent expiry.
FAQs
1. What are the main competitors for this drug?
Competitors include drugs [product names], which hold combined market shares of roughly [percentage].
2. When is patent expiration expected for this drug?
Patent protections are expected to lapse in [year], opening the market to generics.
3. How does reimbursement affect pricing?
Reimbursement levels from Medicare, Medicaid, and private insurers directly impact the net price and market adoption.
4. What factors could accelerate price declines?
Introduction of biosimilars or generics, regulatory pressure on prices, and increased market competition.
5. What is the outlook for market growth?
The market is expected to grow at a compound annual growth rate (CAGR) of approximately [percentage]% through 2027, driven by increasing patient prevalence and expanded indications.
References
- [Cited source 1].
- [Cited source 2].
- [Cited source 3].
- [Cited source 4].
- [Cited source 5].
Note: Specific product data, pricing figures, dates, and market sizes are approximations pending further detailed analysis.
